Assura PLC Total Voting Rights
30 August 2024 - 4:00PM
RNS Regulatory News
RNS Number : 9117A
Assura PLC
30 August 2024
30 August
2024
Assura plc
Total Voting
Rights
In conformity with the FCA's
Disclosure Guidance and Transparency Rules DTR 5.6.1 we hereby
notify that the company's issued share capital consists
of:
Issued shares and voting
rights
3,236,951,244 ordinary shares of 10 pence each
("Shares")
The above figure of 3,236,951,244
shares may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, shares
of Assura plc under the FCA's Disclosure and Transparency Rules. No
shares are held in treasury.
- Ends
-
For more information, please
contact:
Assura plc
|
Tel: 0161 515 2043
|
David Purcell, Investor Relations
Director
|
Email: Investor@assura.co.uk
|
FGS
Global
Gordon Simpson
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
specialist healthcare property investor and developer. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura we BUILD for health and as
the first FTSE 250 certified B Corp we are committed to keeping ESG
at the heart of our strategy, creating Healthy Environments (E) and
Healthy Communities (S) and maintaining a Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a
registered trademark of the European Public Real Estate
Association
Assura plc LEI code: 21380026T19N2Y52XF72
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
TVREAPPNFEKLEEA
Assura (LSE:AGR)
Historical Stock Chart
From Nov 2024 to Dec 2024
Assura (LSE:AGR)
Historical Stock Chart
From Dec 2023 to Dec 2024